Literature DB >> 31894093

Defining niche interactions to target chronic myeloid leukemia stem cells.

Rebecca Mitchell1, Mhairi Copland2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 31894093      PMCID： PMC6939514          DOI： 10.3324/haematol.2019.234898

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  18 in total

1.  The bone marrow microenvironment at single-cell resolution.

Authors:  Anastasia N Tikhonova; Igor Dolgalev; Hai Hu; Kishor K Sivaraj; Edlira Hoxha; Álvaro Cuesta-Domínguez; Sandra Pinho; Ilseyar Akhmetzyanova; Jie Gao; Matthew Witkowski; Maria Guillamot; Michael C Gutkin; Yutong Zhang; Christian Marier; Catherine Diefenbach; Stavroula Kousteni; Adriana Heguy; Hua Zhong; David R Fooksman; Jason M Butler; Aris Economides; Paul S Frenette; Ralf H Adams; Rahul Satija; Aristotelis Tsirigos; Iannis Aifantis
Journal:  Nature       Date:  2019-04-10       Impact factor: 49.962

2.  Long-Term Outcomes of Imatinib Treatment for Chronic Myeloid Leukemia.

Authors:  Andreas Hochhaus; Richard A Larson; François Guilhot; Jerald P Radich; Susan Branford; Timothy P Hughes; Michele Baccarani; Michael W Deininger; Francisco Cervantes; Satoko Fujihara; Christine-Elke Ortmann; Hans D Menssen; Hagop Kantarjian; Stephen G O'Brien; Brian J Druker
Journal:  N Engl J Med       Date:  2017-03-09       Impact factor: 91.245

3.  Requirement for CD44 in homing and engraftment of BCR-ABL-expressing leukemic stem cells.

Authors:  Daniela S Krause; Katherine Lazarides; Ulrich H von Andrian; Richard A Van Etten
Journal:  Nat Med       Date:  2006-09-24       Impact factor: 53.440

4.  Selectins and their ligands are required for homing and engraftment of BCR-ABL1+ leukemic stem cells in the bone marrow niche.

Authors:  Daniela S Krause; Katherine Lazarides; Juliana B Lewis; Ulrich H von Andrian; Richard A Van Etten
Journal:  Blood       Date:  2014-01-06       Impact factor: 22.113

5.  Myeloproliferative neoplasia remodels the endosteal bone marrow niche into a self-reinforcing leukemic niche.

Authors:  Koen Schepers; Eric M Pietras; Damien Reynaud; Johanna Flach; Mikhail Binnewies; Trit Garg; Amy J Wagers; Edward C Hsiao; Emmanuelle Passegué
Journal:  Cell Stem Cell       Date:  2013-07-11       Impact factor: 24.633

6.  Kinetics of in vivo homing and recruitment into cycle of hematopoietic cells are organ-specific but CD44-independent.

Authors:  R A Oostendorp; S Ghaffari; C J Eaves
Journal:  Bone Marrow Transplant       Date:  2000-09       Impact factor: 5.483

7.  Endothelial selectins and vascular cell adhesion molecule-1 promote hematopoietic progenitor homing to bone marrow.

Authors:  P S Frenette; S Subbarao; I B Mazo; U H von Andrian; D D Wagner
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-24       Impact factor: 11.205

8.  L and E selectins in acute myeloid leukemia: expression, clinical relevance and relation to patient outcome.

Authors:  S Aref; O Salama; Y Al-Tonbary; M Fouda; A Menessy; M El-Sherbiny
Journal:  Hematology       Date:  2002-04       Impact factor: 2.269

9.  E-/P-selectins and colon carcinoma metastasis: first in vivo evidence for their crucial role in a clinically relevant model of spontaneous metastasis formation in the lung.

Authors:  S Köhler; S Ullrich; U Richter; U Schumacher
Journal:  Br J Cancer       Date:  2009-12-15       Impact factor: 7.640

Review 10.  The bone marrow niche for haematopoietic stem cells.

Authors:  Sean J Morrison; David T Scadden
Journal:  Nature       Date:  2014-01-16       Impact factor: 49.962
View more
  2 in total

Review 1.  Targeting Abnormal Hematopoietic Stem Cells in Chronic Myeloid Leukemia and Philadelphia Chromosome-Negative Classical Myeloproliferative Neoplasms.

Authors:  Yammy Yung; Emily Lee; Hiu-Tung Chu; Pui-Kwan Yip; Harinder Gill
Journal:  Int J Mol Sci       Date:  2021-01-11       Impact factor: 5.923

Review 2.  Chronic myeloid leukemia stem cells: targeting therapeutic implications.

Authors:  Hanieh Mojtahedi; Niloufar Yazdanpanah; Nima Rezaei
Journal:  Stem Cell Res Ther       Date:  2021-12-18       Impact factor: 6.832
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.